| pubmed-article:10968425 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10968425 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10968425 | lifeskim:mentions | umls-concept:C0324143 | lld:lifeskim |
| pubmed-article:10968425 | lifeskim:mentions | umls-concept:C0460148 | lld:lifeskim |
| pubmed-article:10968425 | lifeskim:mentions | umls-concept:C0227814 | lld:lifeskim |
| pubmed-article:10968425 | lifeskim:mentions | umls-concept:C0694756 | lld:lifeskim |
| pubmed-article:10968425 | lifeskim:mentions | umls-concept:C0012472 | lld:lifeskim |
| pubmed-article:10968425 | lifeskim:mentions | umls-concept:C1268086 | lld:lifeskim |
| pubmed-article:10968425 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:10968425 | lifeskim:mentions | umls-concept:C0332152 | lld:lifeskim |
| pubmed-article:10968425 | lifeskim:mentions | umls-concept:C0021586 | lld:lifeskim |
| pubmed-article:10968425 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:10968425 | pubmed:dateCreated | 2000-10-13 | lld:pubmed |
| pubmed-article:10968425 | pubmed:abstractText | Two trials were conducted to investigate the effects of intrauterine infusion of PGE2 and uterine horn insemination on pregnancy rates in mares achieved by breeding with a suboptimal number of normal spermatozoa. Estrus was synchronized and mares were teased daily with a stallion to detect estrus. Mares in estrus were examined by transrectal palpation and ultrasonography to monitor follicular status. On the first day a 35-mm diameter follicle was present, hCG (1500 IU, iv) was administered and the mares were bred the next day. Mares (Trial 1, n = 34; Trial 2, n = 28) were inseminated with 25 million total spermatozoa from either a stallion with good semen quality (Trial 1) or poor semen quality (Trial 2). In each trial, mares were assigned to 1 of 4 treatment groups as follows: Group PGE-HI - infusion of 0.25 mg PGE2 into the proximal end of the uterine horn ipsilateral to the dominant follicle 2 h prior to insemination in the proximal end of the same uterine horn; Group PGE-BI - infusion of 0.25 mg PGE2 into the proximal end of the uterine horn ipsilateral to the dominant follicle 2 h prior to insemination in the uterine body; Group SAL-HI - infusion of 1 mL sterile saline into the proximal end of the uterine horn ipsilateral to the dominant follicle 2 h prior to insemination in the proximal end of the same uterine horn; or Group SAL-BI - infusion of 1 mL sterile saline into the proximal end of the uterine horn ipsilateral to the dominant follicle 2 h prior to insemination in the uterine body. After breeding, mares were examined daily by transrectal ultrasonography to confirm ovulation, and were re-examined 14 to 16 d after ovulation for pregnancy status. Data were analyzed by Chi-square. Overall pregnancy rates were 59% for stallion 1 and 29% for stallion 2. Group pregnancy rates did not differ for mares bred by either stallion (P > 0.10). Pregnancy rates were not altered by horn insemination for either stallion (P > 0.10). Intrauterine infusion of PGE2 improved pregnancy rate in mares bred by the stallion with good quality semen (P < 0.05), but did not alter pregnancy rate in mares bred by the stallion with poor quality semen (P > 0.10). Further research is warranted to determine if intrauterine infusion of PGE2 will enhance spermatozoal colonization of the oviduct and pregnancy rates in mares, and if PGE-treatment will improve pregnancy rates achieved by subfertile stallions. | lld:pubmed |
| pubmed-article:10968425 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10968425 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10968425 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10968425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10968425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10968425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10968425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10968425 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10968425 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10968425 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:10968425 | pubmed:issn | 0093-691X | lld:pubmed |
| pubmed-article:10968425 | pubmed:author | pubmed-author:StephensRR | lld:pubmed |
| pubmed-article:10968425 | pubmed:author | pubmed-author:WoodsJJ | lld:pubmed |
| pubmed-article:10968425 | pubmed:author | pubmed-author:VarnerDD | lld:pubmed |
| pubmed-article:10968425 | pubmed:author | pubmed-author:BlanchardTT | lld:pubmed |
| pubmed-article:10968425 | pubmed:author | pubmed-author:RigbySS | lld:pubmed |
| pubmed-article:10968425 | pubmed:author | pubmed-author:BrinskoSS | lld:pubmed |
| pubmed-article:10968425 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10968425 | pubmed:volume | 53 | lld:pubmed |
| pubmed-article:10968425 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10968425 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10968425 | pubmed:pagination | 1827-36 | lld:pubmed |
| pubmed-article:10968425 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:meshHeading | pubmed-meshheading:10968425... | lld:pubmed |
| pubmed-article:10968425 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10968425 | pubmed:articleTitle | Effect of intrauterine treatment with prostaglandin E2 prior to insemination of mares in the uterine horn or body. | lld:pubmed |
| pubmed-article:10968425 | pubmed:affiliation | Department of Large Animal Medicine and Surgery, College of Veterinary Medicine, Texas A&M University, College Station 77843-4475, USA. | lld:pubmed |
| pubmed-article:10968425 | pubmed:publicationType | Journal Article | lld:pubmed |
